NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 19,100
+3,160 (19.82%)
At close: Aug 20, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 217.12 billion as of August 20, 2026. Its market cap has decreased by -22.87% in one year.
Market Cap
217.12B
Enterprise Value
202.66B
Revenue
32.34B
Ranking
n/a
PE Ratio
29.75
Stock Price
19,100.00
ChartMarket Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 217.12B, an increase of 480.02%. That is a compound annual growth rate of 12.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 217.12B | -49.11% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 242.66B |
| S.Biomedics | 235.32B |
| curacle co.,ltd. | 233.49B |
| Genome & Company | 221.23B |
| Kanaph Therapeutics | 194.82B |
| Bio Solution | 187.08B |
| Prestige Biologics | 144.31B |
| Y-Biologics | 143.22B |